Tropicamide is a medication primarily used in ophthalmology to dilate the pupil (mydriasis) and to paralyze the ciliary muscle (cycloplegia) for eye examinations. Understanding the mechanism of Tropicamide provides insight into how this drug functions in clinical practice, particularly in facilitating thorough eye examinations and certain surgical procedures.
Tropicamide is classified as an antimuscarinic agent or a muscarinic antagonist. It works by blocking the
muscarinic receptors in the eye. The eye contains various types of muscarinic receptors, which are a subtype of
acetylcholine receptors. Acetylcholine is a neurotransmitter that, among many other functions, is responsible for the contraction of smooth muscles in the eye. When acetylcholine binds to muscarinic receptors on the sphincter pupillae muscle (which constricts the pupil) and the ciliary muscle (which controls the shape of the lens), it causes these muscles to contract.
By blocking these muscarinic receptors, Tropicamide prevents
acetylcholine from exerting its effects. This leads to relaxation of the sphincter pupillae muscle, resulting in pupil dilation (
mydriasis). Additionally, the relaxation of the ciliary muscle leads to a temporary loss of accommodation, meaning the eye is unable to focus on nearby objects (cycloplegia). These effects are essential for thorough retinal examinations and some diagnostic procedures.
The onset of action for Tropicamide is relatively quick. After administration into the eye, the pupil begins to dilate within 15 to 30 minutes. The peak effect typically occurs within 20 to 40 minutes. The effects of Tropicamide are temporary, usually lasting for about 4 to 6 hours, though this can vary depending on the individual's response to the medication.
In clinical settings, Tropicamide is often used in combination with other mydriatic agents such as
phenylephrine to achieve more pronounced dilation. However, Tropicamide alone is effective for routine examinations. It is also used preoperatively to prepare the eye for surgical procedures such as cataract extraction.
Despite its usefulness, Tropicamide can have side effects, which are generally mild and transient. Common side effects include stinging or burning in the eye upon instillation, increased intraocular pressure, and blurred vision. Systemic side effects are rare but can include
dry mouth,
headache, and
increased heart rate due to its anticholinergic properties.
In summary, Tropicamide is a valuable tool in ophthalmology, functioning as an antimuscarinic agent that blocks acetylcholine at muscarinic receptors in the eye. This action leads to pupil dilation and
paralysis of the ciliary muscle, facilitating comprehensive eye examinations and various medical procedures. Its rapid onset and relatively short duration of action make it an ideal choice for temporary mydriasis and cycloplegia.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


